nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ORM1—saliva—nicotine dependence	0.0654	0.388	CbGeAlD
Vemurafenib—VIIth nerve paralysis—Varenicline—nicotine dependence	0.0451	0.1	CcSEcCtD
Vemurafenib—Rash generalised—Varenicline—nicotine dependence	0.0435	0.0969	CcSEcCtD
Vemurafenib—Cyst—Varenicline—nicotine dependence	0.0277	0.0616	CcSEcCtD
Vemurafenib—BRAF—midbrain—nicotine dependence	0.0224	0.133	CbGeAlD
Vemurafenib—RAF1—cardiovascular system—nicotine dependence	0.0191	0.113	CbGeAlD
Vemurafenib—Musculoskeletal pain—Varenicline—nicotine dependence	0.0187	0.0417	CcSEcCtD
Vemurafenib—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0149	0.039	CbGpPWpGaD
Vemurafenib—RAF1—midbrain—nicotine dependence	0.0149	0.0886	CbGeAlD
Vemurafenib—Atrial fibrillation—Varenicline—nicotine dependence	0.0142	0.0315	CcSEcCtD
Vemurafenib—BRAF—brain—nicotine dependence	0.0141	0.0836	CbGeAlD
Vemurafenib—Arthritis—Varenicline—nicotine dependence	0.0138	0.0308	CcSEcCtD
Vemurafenib—Dry skin—Varenicline—nicotine dependence	0.0123	0.0274	CcSEcCtD
Vemurafenib—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.0116	0.0304	CbGpPWpGaD
Vemurafenib—Photosensitivity reaction—Varenicline—nicotine dependence	0.0106	0.0236	CcSEcCtD
Vemurafenib—Infestation NOS—Varenicline—nicotine dependence	0.0103	0.023	CcSEcCtD
Vemurafenib—Infestation—Varenicline—nicotine dependence	0.0103	0.023	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.0103	0.0228	CcSEcCtD
Vemurafenib—RAF1—brain—nicotine dependence	0.00937	0.0557	CbGeAlD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00925	0.0242	CbGpPWpGaD
Vemurafenib—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00925	0.0242	CbGpPWpGaD
Vemurafenib—Oedema peripheral—Varenicline—nicotine dependence	0.00915	0.0204	CcSEcCtD
Vemurafenib—Connective tissue disorder—Varenicline—nicotine dependence	0.00912	0.0203	CcSEcCtD
Vemurafenib—Erythema multiforme—Varenicline—nicotine dependence	0.00878	0.0196	CcSEcCtD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00877	0.0229	CbGpPWpGaD
Vemurafenib—Eye disorder—Varenicline—nicotine dependence	0.00868	0.0193	CcSEcCtD
Vemurafenib—Cardiac disorder—Varenicline—nicotine dependence	0.00862	0.0192	CcSEcCtD
Vemurafenib—Angiopathy—Varenicline—nicotine dependence	0.00842	0.0188	CcSEcCtD
Vemurafenib—Mediastinal disorder—Varenicline—nicotine dependence	0.00837	0.0186	CcSEcCtD
Vemurafenib—Chills—Varenicline—nicotine dependence	0.00833	0.0186	CcSEcCtD
Vemurafenib—Malnutrition—Varenicline—nicotine dependence	0.00808	0.018	CcSEcCtD
Vemurafenib—Erythema—Varenicline—nicotine dependence	0.00808	0.018	CcSEcCtD
Vemurafenib—Dysgeusia—Varenicline—nicotine dependence	0.00791	0.0176	CcSEcCtD
Vemurafenib—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00783	0.0205	CbGpPWpGaD
Vemurafenib—Back pain—Varenicline—nicotine dependence	0.00782	0.0174	CcSEcCtD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00735	0.0192	CbGpPWpGaD
Vemurafenib—Cough—Varenicline—nicotine dependence	0.00705	0.0157	CcSEcCtD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00695	0.0182	CbGpPWpGaD
Vemurafenib—Arthralgia—Varenicline—nicotine dependence	0.00688	0.0153	CcSEcCtD
Vemurafenib—Myalgia—Varenicline—nicotine dependence	0.00688	0.0153	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00683	0.0152	CcSEcCtD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00659	0.0172	CbGpPWpGaD
Vemurafenib—Infection—Varenicline—nicotine dependence	0.00655	0.0146	CcSEcCtD
Vemurafenib—Nervous system disorder—Varenicline—nicotine dependence	0.00647	0.0144	CcSEcCtD
Vemurafenib—Skin disorder—Varenicline—nicotine dependence	0.00641	0.0143	CcSEcCtD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.0064	0.0167	CbGpPWpGaD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00634	0.0166	CbGpPWpGaD
Vemurafenib—ABCG2—midbrain—nicotine dependence	0.00617	0.0367	CbGeAlD
Vemurafenib—Hypotension—Varenicline—nicotine dependence	0.00616	0.0137	CcSEcCtD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00608	0.0159	CbGpPWpGaD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00607	0.0159	CbGpPWpGaD
Vemurafenib—BRAF—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00605	0.0158	CbGpPWpGaD
Vemurafenib—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00605	0.0158	CbGpPWpGaD
Vemurafenib—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00601	0.0134	CcSEcCtD
Vemurafenib—Decreased appetite—Varenicline—nicotine dependence	0.00573	0.0128	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00569	0.0127	CcSEcCtD
Vemurafenib—Fatigue—Varenicline—nicotine dependence	0.00569	0.0127	CcSEcCtD
Vemurafenib—ALB—brain—nicotine dependence	0.00567	0.0337	CbGeAlD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00565	0.0148	CbGpPWpGaD
Vemurafenib—Constipation—Varenicline—nicotine dependence	0.00564	0.0126	CcSEcCtD
Vemurafenib—BRAF—Neuronal System—CHRNB3—nicotine dependence	0.00533	0.0139	CbGpPWpGaD
Vemurafenib—BRAF—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00526	0.0138	CbGpPWpGaD
Vemurafenib—Body temperature increased—Varenicline—nicotine dependence	0.00521	0.0116	CcSEcCtD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00508	0.0133	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—CHRNA6—nicotine dependence	0.00505	0.0132	CbGpPWpGaD
Vemurafenib—Hypersensitivity—Varenicline—nicotine dependence	0.00486	0.0108	CcSEcCtD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00481	0.0126	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00477	0.0125	CbGpPWpGaD
Vemurafenib—Asthenia—Varenicline—nicotine dependence	0.00473	0.0105	CcSEcCtD
Vemurafenib—ABCC1—brain—nicotine dependence	0.00468	0.0278	CbGeAlD
Vemurafenib—Pruritus—Varenicline—nicotine dependence	0.00467	0.0104	CcSEcCtD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00461	0.012	CbGpPWpGaD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00457	0.0119	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00457	0.0119	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00456	0.0119	CbGpPWpGaD
Vemurafenib—Diarrhoea—Varenicline—nicotine dependence	0.00451	0.0101	CcSEcCtD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.00439	0.0115	CbGpPWpGaD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00438	0.0115	CbGpPWpGaD
Vemurafenib—Dizziness—Varenicline—nicotine dependence	0.00436	0.00971	CcSEcCtD
Vemurafenib—BRAF—Signaling by NGF—FGD1—nicotine dependence	0.00436	0.0114	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00425	0.0111	CbGpPWpGaD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.00421	0.011	CbGpPWpGaD
Vemurafenib—Vomiting—Varenicline—nicotine dependence	0.00419	0.00934	CcSEcCtD
Vemurafenib—RAF1—ErbB1 downstream signaling—WASF2—nicotine dependence	0.00419	0.0109	CbGpPWpGaD
Vemurafenib—Rash—Varenicline—nicotine dependence	0.00416	0.00926	CcSEcCtD
Vemurafenib—Dermatitis—Varenicline—nicotine dependence	0.00416	0.00925	CcSEcCtD
Vemurafenib—Headache—Varenicline—nicotine dependence	0.00413	0.0092	CcSEcCtD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—WASF2—nicotine dependence	0.00412	0.0108	CbGpPWpGaD
Vemurafenib—RAF1—TCR Signaling Pathway—OPRM1—nicotine dependence	0.00409	0.0107	CbGpPWpGaD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00406	0.0106	CbGpPWpGaD
Vemurafenib—RAF1—VEGFA-VEGFR2 Pathway—WASF1—nicotine dependence	0.00395	0.0103	CbGpPWpGaD
Vemurafenib—Nausea—Varenicline—nicotine dependence	0.00392	0.00873	CcSEcCtD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.00391	0.0102	CbGpPWpGaD
Vemurafenib—RAF1—Ion channel transport—GABRA4—nicotine dependence	0.0039	0.0102	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—WASF2—nicotine dependence	0.00389	0.0102	CbGpPWpGaD
Vemurafenib—ABCG2—brain—nicotine dependence	0.00388	0.023	CbGeAlD
Vemurafenib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00384	0.01	CbGpPWpGaD
Vemurafenib—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00379	0.0099	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by VEGF—WASF1—nicotine dependence	0.00373	0.00975	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—CHRNB3—nicotine dependence	0.00369	0.00964	CbGpPWpGaD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00368	0.00963	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—GABRA4—nicotine dependence	0.00365	0.00955	CbGpPWpGaD
Vemurafenib—RAF1—PDGFR-beta signaling pathway—WASF2—nicotine dependence	0.00364	0.00951	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—CHRNB4—nicotine dependence	0.0035	0.00915	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—CHRNA6—nicotine dependence	0.0035	0.00913	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00346	0.00905	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.0033	0.00862	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—CHRNA5—nicotine dependence	0.00326	0.00851	CbGpPWpGaD
Vemurafenib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00325	0.0085	CbGpPWpGaD
Vemurafenib—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00321	0.00839	CbGpPWpGaD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.00319	0.00833	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00316	0.00827	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00316	0.00826	CbGpPWpGaD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00311	0.00814	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00305	0.00797	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00303	0.00793	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—FGD1—nicotine dependence	0.00302	0.00788	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00294	0.00768	CbGpPWpGaD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.00281	0.00733	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00277	0.00724	CbGpPWpGaD
Vemurafenib—CYP2D6—brain—nicotine dependence	0.00266	0.0158	CbGeAlD
Vemurafenib—BRAF—Neuronal System—CHRNA3—nicotine dependence	0.00265	0.00694	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00264	0.00689	CbGpPWpGaD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.00255	0.00666	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—GABRA4—nicotine dependence	0.00253	0.0066	CbGpPWpGaD
Vemurafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00251	0.00656	CbGpPWpGaD
Vemurafenib—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00248	0.00647	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—CHRNB4—nicotine dependence	0.00242	0.00633	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.0024	0.00626	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—CHRNB2—nicotine dependence	0.00234	0.00611	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—CHRNA5—nicotine dependence	0.00225	0.00589	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—CHRNA4—nicotine dependence	0.00212	0.00554	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00211	0.00551	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00204	0.00532	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00192	0.00501	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—CHRNA3—nicotine dependence	0.00184	0.0048	CbGpPWpGaD
Vemurafenib—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00175	0.00458	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00165	0.00432	CbGpPWpGaD
Vemurafenib—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00163	0.00426	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—CHRNB2—nicotine dependence	0.00162	0.00422	CbGpPWpGaD
Vemurafenib—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00149	0.00388	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—CHRNA4—nicotine dependence	0.00147	0.00384	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.0014	0.00366	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—TAS2R16—nicotine dependence	0.0014	0.00365	CbGpPWpGaD
Vemurafenib—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00138	0.00361	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00136	0.00355	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00135	0.00352	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TAS2R16—nicotine dependence	0.00119	0.00312	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00119	0.0031	CbGpPWpGaD
Vemurafenib—BRAF—Disease—AKR1B10—nicotine dependence	0.00118	0.00309	CbGpPWpGaD
Vemurafenib—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00115	0.003	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—FGD1—nicotine dependence	0.0011	0.00287	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00108	0.00283	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—WASF2—nicotine dependence	0.00107	0.0028	CbGpPWpGaD
Vemurafenib—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00107	0.00279	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—WASF1—nicotine dependence	0.00103	0.00268	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—FGD1—nicotine dependence	0.000936	0.00245	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—AKR1B10—nicotine dependence	0.000827	0.00216	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TAS2R16—nicotine dependence	0.000826	0.00216	CbGpPWpGaD
Vemurafenib—RAF1—Disease—AKR1B10—nicotine dependence	0.000817	0.00214	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—AKR1B10—nicotine dependence	0.00081	0.00212	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000731	0.00191	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGD1—nicotine dependence	0.000648	0.00169	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.000631	0.00165	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—WASF2—nicotine dependence	0.000624	0.00163	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—WASF1—nicotine dependence	0.000598	0.00156	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—OPRM1—nicotine dependence	0.000589	0.00154	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—WASF2—nicotine dependence	0.000583	0.00152	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AKR1B10—nicotine dependence	0.000572	0.0015	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—WASF1—nicotine dependence	0.000559	0.00146	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000555	0.00145	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—OPRM1—nicotine dependence	0.000503	0.00131	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—DRD2—nicotine dependence	0.000426	0.00111	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—WASF2—nicotine dependence	0.000403	0.00105	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—WASF1—nicotine dependence	0.000387	0.00101	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—DRD2—nicotine dependence	0.000364	0.000951	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—OPRM1—nicotine dependence	0.000348	0.00091	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CYP2A7—nicotine dependence	0.000342	0.000895	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000283	0.000739	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DRD2—nicotine dependence	0.000252	0.000658	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.00024	0.000626	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000185	0.000483	CbGpPWpGaD
